# 🚀 PharmAI: Future Roadmap

This document outlines the strategic vision for **PharmAI**, detailing the next phase of features designed to enhance clinical safety, expand accessibility, and deepen integration with the healthcare ecosystem.

---

## 1. 🛡️ Clinical Safety & Intelligence
*Focus: Deepening the medical utility of the platform to prevent errors and improve health outcomes.*

*   **Drug Interaction Matrix**:
    *   **Goal**: Real-time cross-referencing of prescribed medications to flag potential Adverse Drug Reactions (ADRs).
    *   **Mechanism**: Maintain a vector database of molecular interactions (e.g., *Warfarin + Aspirin*) and alert pharmacists/users during prescription scanning.

*   **Contraindications & Allergy Safety Net**:
    *   **Goal**: Personalized safety checks based on user profiles.
    *   **Mechanism**: Allow users to store a secure medical profile (e.g., "History of asthma," "Penicillin allergy"). The AI scans prescriptions against this profile to warn of contraindicated drugs.

*   **Smart Dosage Validation**:
    *   **Goal**: Prevent overdose or under-dosing errors.
    *   **Mechanism**: Analyze the *frequency* and *dosage unit* (mg/ml) in the prescription against standard pediatric/adult dosage guidelines for that specific molecule.

---

## 2. 🗣️ User Experience & Accessibility
*Focus: Making the platform usable by the "next billion users" (NBU) in India.*

*   **WhatsApp Integration (Twilio/Meta)**:
    *   **Goal**: Meet users where they are.
    *   **Mechanism**: Users simply forward an image of a prescription or voice note to a PharmAI WhatsApp bot. The bot replies with the digitized text, generic alternatives, and audio explanation in their language.
  
*   **Voice-First Mode for Elderly**:
    *   **Goal**: Complete hands-free navigation for non-tech-savvy/elderly users.
    *   **Mechanism**: A "Big Button" interface where the entire interaction—from querying a drug to finding a Jan Aushadhi substitute—happens via conversational voice AI (using Sarvam/Bhashini).

*   **Hyper-Local Regional Language Expansion**:
    *   **Goal**: Beyond Hindi/English to cover all 22 scheduled languages.
    *   **Mechanism**: Integrate specialized models for languages with complex scripts (e.g., Malayalam, Odia) to ensure rural populations in every state are covered.

---

## 3. 🏥 Data & Ecosystem Integration
*Focus: connecting the isolated silos of Indian healthcare.*

*   **Pharmacist Professional Dashboard**:
    *   **Goal**: A B2B tool for retail pharmacies.
    *   **Mechanism**: A desktop view for pharmacists to verify Schedule H/H1 status, log dispensed prescriptions digitally (compliance), and instantly print generic substitution options for customers.

*   **ABHA (Ayushman Bharat Health Account) Integration**:
    *   **Goal**: Interoperability with India's National Digital Health Mission (NDHM).
    *   **Mechanism**: Allow users to link their PharmAI history to their ABHA ID, enabling seamless sharing of medication history with doctors.

*   **Inventory Sync**:
    *   **Goal**: "Is this generic available near me?"
    *   **Mechanism**: API integration with local Jan Aushadhi Kendra inventory systems to show real-time stock availability of the recommended affordable medicines.

---

## 4. ⚙️ Technical Excellence
*Focus: Robustness, speed, and capability expansion.*

*   **Offline-First PWA (Progressive Web App)**:
    *   **Goal**: Functional in low-connectivity rural areas.
    *   **Mechanism**: Cache critical Jan Aushadhi databases and CDSCO banned lists locally on the device, allowing essential checks even without active internet.

*   **Response Streaming**:
    *   **Goal**: Reduce perceived latency.
    *   **Mechanism**: Implement Server-Sent Events (SSE) to stream the AI's analysis of a prescription token-by-token, making the UI feel instant even for complex OCR tasks.

*   **Multi-Modal Analysis (X-Rays & Lab Reports)**:
    *   **Goal**: comprehensive health understanding.
    *   **Mechanism**: Train visual models to interpret lab report values (e.g., "High Creatinine") and correlate them with prescribed nephrotoxic drugs to issue warnings.

---

*This roadmap is a living document. Priorities may shift based on user feedback and regulatory changes.*
